Literature DB >> 24811245

GERD symptoms in the general population: prevalence and severity versus care-seeking patients.

Erica Cohen1, Roger Bolus, Dinesh Khanna, Ron D Hays, Lin Chang, Gil Y Melmed, Puja Khanna, Brennan Spiegel.   

Abstract

BACKGROUND: Prior estimates suggest that up to 40% of the US general population (GP) report symptoms of gastroesophageal reflux disease (GERD). However, symptoms in the GP versus patients seeking care for gastrointestinal (GI) complaints have not been compared. We estimated the prevalence and severity of GERD symptoms in the GP versus GI patients, and identified predictors of GERD severity. We hypothesized that similar to functional GI disorders, psychosocial factors would predict symptom severity in GERD as much, or perhaps more, than care-seeking behavior alone.
METHODS: We compared the prevalence of heartburn and regurgitation between a sample from the US GP and patients seeking GI specialty care. We compared GERD severity between groups using the NIH PROMIS(®) GERD scale. We then performed multivariable regression to identify predictors of GERD severity.
RESULTS: There was no difference in the prevalence of heartburn between the GP and patient groups (59 vs. 59%), but regurgitation was more common in patients versus GP (46 vs. 39%; p = 0.004). In multivariable regression, having high visceral anxiety (p < 0.001) and being divorced or separated (p = 0.006) were associated with higher GERD severity.
CONCLUSIONS: More than half of a GP sample reports heartburn-higher than previous series and no different from GI patients. Although regurgitation was more prevalent in patients versus the GP, there was no difference in GERD severity between groups after adjusting for other factors; care seeking in GERD appears related to factors beyond symptoms, including visceral anxiety.

Entities:  

Mesh:

Year:  2014        PMID: 24811245      PMCID: PMC4275099          DOI: 10.1007/s10620-014-3181-8

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  32 in total

1.  Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota.

Authors:  G R Locke; N J Talley; S L Fett; A R Zinsmeister; L J Melton
Journal:  Gastroenterology       Date:  1997-05       Impact factor: 22.682

2.  The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence.

Authors:  Heiko Pohl; H Gilbert Welch
Journal:  J Natl Cancer Inst       Date:  2005-01-19       Impact factor: 13.506

3.  The central role of gastrointestinal-specific anxiety in irritable bowel syndrome: further validation of the visceral sensitivity index.

Authors:  Jennifer S Labus; Emeran A Mayer; Lin Chang; Roger Bolus; Bruce D Naliboff
Journal:  Psychosom Med       Date:  2007-01       Impact factor: 4.312

4.  Risk factors associated with symptoms of gastroesophageal reflux.

Authors:  G R Locke; N J Talley; S L Fett; A R Zinsmeister; L J Melton
Journal:  Am J Med       Date:  1999-06       Impact factor: 4.965

Review 5.  Systematic review: the association between symptomatic response to proton pump inhibitors and health-related quality of life in patients with gastro-oesophageal reflux disease.

Authors:  A Becher; H El-Serag
Journal:  Aliment Pharmacol Ther       Date:  2011-07-20       Impact factor: 8.171

6.  Comparative study of characteristics and disease management between subjects with frequent and occasional gastro-oesophageal reflux symptoms.

Authors:  J F Bretagne; C Honnorat; B Richard-Molard; A Caekaert; P Barthélemy
Journal:  Aliment Pharmacol Ther       Date:  2006-03-01       Impact factor: 8.171

7.  Psychological factors in the irritable bowel syndrome.

Authors:  M Solmaz; I Kavuk; K Sayar
Journal:  Eur J Med Res       Date:  2003-12-09       Impact factor: 2.175

8.  The effect of life stress on symptoms of heartburn.

Authors:  Bruce D Naliboff; Minou Mayer; Ronnie Fass; Leah Z Fitzgerald; Lin Chang; Roger Bolus; Emeran A Mayer
Journal:  Psychosom Med       Date:  2004 May-Jun       Impact factor: 4.312

9.  Development of the NIH Patient-Reported Outcomes Measurement Information System (PROMIS) gastrointestinal symptom scales.

Authors:  Brennan M R Spiegel; Ron D Hays; Roger Bolus; Gil Y Melmed; Lin Chang; Cynthia Whitman; Puja P Khanna; Sylvia H Paz; Tonya Hays; Steve Reise; Dinesh Khanna
Journal:  Am J Gastroenterol       Date:  2014-09-09       Impact factor: 10.864

Review 10.  The role of psychosocial factors and psychiatric disorders in functional dyspepsia.

Authors:  Lukas Van Oudenhove; Qasim Aziz
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-01-29       Impact factor: 46.802

View more
  18 in total

1.  Characterization of Mast Cell Activation Syndrome.

Authors:  Lawrence B Afrin; Sally Self; Jeremiah Menk; John Lazarchick
Journal:  Am J Med Sci       Date:  2016-12-16       Impact factor: 2.378

2.  Diet and Rheumatoid Arthritis Symptoms: Survey Results From a Rheumatoid Arthritis Registry.

Authors:  Sara K Tedeschi; Michelle Frits; Jing Cui; Zhi Zack Zhang; Taysir Mahmoud; Christine Iannaccone; Tzu-Chieh Lin; Kazuki Yoshida; Michael E Weinblatt; Nancy A Shadick; Daniel H Solomon
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-12       Impact factor: 4.794

3.  Objective Measures of Swallowing Function Applied to the Dysphagia Population: A One Year Experience.

Authors:  Katherine A Kendall; Julia Ellerston; Amanda Heller; Daniel R Houtz; Chong Zhang; Angela P Presson
Journal:  Dysphagia       Date:  2016-04-22       Impact factor: 3.438

Review 4.  Integrative Medicine for Gastrointestinal Disease.

Authors:  Michelle L Dossett; Ezra M Cohen; Jonah Cohen
Journal:  Prim Care       Date:  2017-06       Impact factor: 2.907

5.  Higher clinical suspicion is needed for prompt diagnosis of esophageal adenocarcinoma in young patients.

Authors:  Tamar B Nobel; Michael Curry; Renee Gennarelli; David R Jones; Daniela Molena
Journal:  J Thorac Cardiovasc Surg       Date:  2019-04-16       Impact factor: 5.209

6.  Gastrointestinal symptom severity in irritable bowel syndrome, inflammatory bowel disease and the general population.

Authors:  A D Lee; B M Spiegel; R D Hays; G Y Melmed; R Bolus; D Khanna; P P Khanna; L Chang
Journal:  Neurogastroenterol Motil       Date:  2016-12-16       Impact factor: 3.598

7.  Tri-comparison of Laparoscopic Nissen, Hill, and Nissen-Hill Hybrid Repairs for Uncomplicated Gastroesophageal Reflux Disease.

Authors:  Andreas M Schneider; Ralph W Aye; Candice L Wilshire; Alexander S Farivar; Brian E Louie
Journal:  J Gastrointest Surg       Date:  2016-11-03       Impact factor: 3.452

8.  Hiatal hernia and gastroesophageal reflux: Study of collagen in the phrenoesophageal ligament.

Authors:  V von Diemen; E N Trindade; M R M Trindade
Journal:  Surg Endosc       Date:  2016-03-22       Impact factor: 4.584

9.  Esophageal hypervigilance is prevalent across gastroesophageal reflux disease presentations.

Authors:  Livia Guadagnoli; Rena Yadlapati; Tiffany Taft; John E Pandolfino; Michael Tye; Laurie Keefer
Journal:  Neurogastroenterol Motil       Date:  2021-01-11       Impact factor: 3.960

10.  Are Anxious and Depressive Symptoms Associated with Gastrointestinal Symptoms in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL)?

Authors:  Marisa J Perera; Neil Schneiderman; Daniela Sotres-Alvarez; Martha Daviglus; Silvia M Mirabal; Maria M Llabre
Journal:  J Racial Ethn Health Disparities       Date:  2020-08-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.